WWP
NVO

Walden Wealth Partners’s Novo Nordisk NVO Stock Holding History

Walden Wealth Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$639K Hold
4,479
– – 0.36% 42
2024
Q1 		$555K Buy
4,479
+175
+4% +$20.8K 0.32% 44
2023
Q4 		$445K Buy
+4,304
New +$426K 0.28% 48

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Walden Wealth Partners's NVO Position: Q2 2024 in Review

Walden Wealth Partners held its Novo Nordisk (NVO) position steady in Q2 2024 at 4,479 shares worth $639K. The position accounts for 0.36% of the portfolio, ranked #42.

Walden Wealth Partners first reported a position in NVO in Q4 2023 and has held it in 3 quarters since. 1,860 funds tracked by Wall St. Rank hold NVO as of Q2 2024.

  • Walden Wealth Partners held 4,479 shares of Novo Nordisk worth $639K as of Q2 2024.
  • Walden Wealth Partners left its Novo Nordisk share count unchanged in Q2 2024.
  • Novo Nordisk made up 0.36% of Walden Wealth Partners's portfolio in Q2 2024, its #42 holding.
  • Walden Wealth Partners first reported a position in Novo Nordisk in Q4 2023 and has held it in 3 quarters since.
  • 1,860 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2024.

Based on Walden Wealth Partners's 13F filing for Q2 2024, filed 11 Jul 2024.